PA173134

Mycobacterium tuberculosis Polyclonal Antibody, FITC, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PA173134-Each-of-1 In Stock ₹ 50,685.50

PA173134 - Each of 1

₹ 50,685.50

In Stock

Quantity

1

Base Price: ₹ 50,685.50

GST (18%): ₹ 9,123.39

Total Price: ₹ 59,808.89

Antigen

Mycobacterium tuberculosis

Classification

Polyclonal

Conjugate

FITC

Gene Alias

m tuberculosis; M. tuberculosis

Immunogen

Purified PPD from Mycobacterium tuberculosis.

Quantity

1 mL

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. Store in the dark.

Form

Liquid

Applications

Immunohistochemistry

Concentration

4-5 mg/mL

Formulation

PBS with 10mg/mL BSA and 0.1% sodium azide; pH 7.2

Host Species

Rabbit

Purification Method

IgG fraction

Regulatory Status

RUO

Target Species

Bacteria

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PA173135

--

Img

Thermo Scientific

PA17232

--

Img

Thermo Scientific

PIPA120615

--

Img

Thermo Scientific

PIPA5107001

--

Img

Thermo Scientific

PIMA548046

--

Img

Thermo Scientific

PIPA5116282

--

Img

Thermo Scientific

PIPA5101681

--

Img

Thermo Scientific

PIMA538586

--

Description

  • The PA1-73134 antibody reacts with Mycobacterium tuberculosis
  • PA1-73134 has been successfully used in Immunohistochemistry applications
  • The PA1-73134 antibody was raised against purified PPD from Mycobacterium tuberculosis
  • Tuberculosis is a chronic bacterial infection which remains one of the leading killers of young adults world wide
  • Mycobacterium tuberculosis enters the alveoli by airborne transmission
  • They are engulfed by alveolar macrophages but resist destruction
  • Although the exact mechanism is not known, it is suspected that that Mycrobacterium tuberculosis survives by preventing the fusion of the phagosome and lysosome
  • As the bacterium accumulates it forms a tubercle, spreads to the lymph nodes and becomes a systemic infection
  • Although treatments for tuberculosis do exist, new strains of Mycobacterium tuberculosis that appear to have multiple-drug resistance (MDR) pose a considerable threat to public health.